Fresh Tracks Therapeutics (NASDAQ:FRTX) Trading 1.4% Higher – Still a Buy?

Shares of Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTXGet Free Report) traded up 1.4% during trading on Wednesday . The stock traded as high as $0.74 and last traded at $0.74. 1,545 shares were traded during mid-day trading, a decline of 89% from the average session volume of 14,401 shares. The stock had previously closed at $0.73.

Fresh Tracks Therapeutics Trading Up 1.4 %

The firm has a market capitalization of $4.42 million, a PE ratio of -0.52 and a beta of 0.48. The firm’s fifty day moving average price is $0.74 and its 200 day moving average price is $0.85.

About Fresh Tracks Therapeutics

(Get Free Report)

Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.

Read More

Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.